TY - JOUR
T1 - A new clustering method identifies multiple sclerosis-specific T-cell receptors
AU - Hayashi, Fumie
AU - Isobe, Noriko
AU - Glanville, Jacob
AU - Matsushita, Takuya
AU - Maimaitijiang, Guzailiayi
AU - Fukumoto, Shoko
AU - Watanabe, Mitsuru
AU - Masaki, Katsuhisa
AU - Kira, Jun ichi
N1 - Funding Information:
This study was supported by grants from the Japan Society for the Promotion of Science [Grant Nos. 16H02657 (to J.K.), 16K09694 (to K.M), 18K07529 (to N.I.), 19H01045 (to J.K.), 19K07995 (to M.W.), and 19K07997 (to T.M., M.W., and N.I.)], and a Health and Labour Sciences Research Grant on Intractable Diseases [H29‐Nanchitou (Nan)‐Ippan‐043 and 20FC1030 (to J.K.)] from the Ministry of Health, Labour, and Welfare, Japan. We thank Edanz Group ( https://en‐author‐services.edanzgroup.com/ac ) for editing a draft of this manuscript.
Funding Information:
N.I. received grant support from Mitsubishi Tanabe Pharma, Osoegawa Neurology Clinic, Bayer Yakuhin Ltd., and Japan Blood Products Organization. T.M. received speaker honoraria payments from Takeda Pharmaceutical Company and Biogen Japan. M.W. received speaker honoraria and consultant fees from Novartis Pharma. J.K. is a consultant for Biogen Japan and Medical Review, and has received honoraria from Bayer Healthcare, Mitsubishi Tanabe Pharma, Nobelpharma, Otsuka Pharmaceutical, Sanofi K.K., Chugai Pharmaceutical Co. Ltd., Teijin Pharma, Novartis Pharma, and Medical Review.
Publisher Copyright:
© 2020 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association
PY - 2021/1
Y1 - 2021/1
N2 - Objective: To characterize T-cell receptors (TCRs) and identify target epitopes in multiple sclerosis (MS). Methods: Peripheral blood mononuclear cells were obtained from 39 MS patients and 19 healthy controls (HCs). TCR repertoires for α/β/δ/γ chains, TCR diversity, and V/J usage were determined by next-generation sequencing. TCR β chain repertoires were compared with affectation status using a novel clustering method, Grouping of Lymphocyte Interactions by Paratope Hotspots (GLIPH). Cytomegalovirus (CMV)-IgG was measured in an additional 113 MS patients and 93 HCs. Regulatory T cells (Tregs) were measured by flow cytometry. Results: TCR diversity for all four chains decreased with age. TCRα and TCRβ diversity was higher in MS patients (P = 0.0015 and 0.024, respectively), even after age correction. TRAJ56 and TRBV4-3 were more prevalent in MS patients than in HCs (pcorr = 0.027 and 0.040, respectively). GLIPH consolidated 208,674 TCR clones from MS patients into 1,294 clusters, among which two candidate clusters were identified. The TRBV4-3 cluster was shared by HLA-DRB1*04:05-positive patients (87.5%) and predicted to recognize CMV peptides (CMV-TCR). MS Severity Score (MSSS) was lower in patients with CMV-TCR than in those without (P = 0.037). CMV-IgG-positivity was associated with lower MSSS in HLA-DRB1*04:05 carriers (P = 0.0053). HLA-DRB1*04:05-positive individuals demonstrated higher CMV-IgG titers than HLA-DRB1*04:05-negative individuals (P = 0.017). CMV-IgG-positive patients had more Tregs than CMV-IgG-negative patients (P = 0.054). Interpretation: High TCRα/TCRβ diversity, regardless of age, is characteristic of MS. Association of a CMV-recognizing TCR with mild disability indicates CMV’s protective role in HLA-DRB1*04:05-positive MS.
AB - Objective: To characterize T-cell receptors (TCRs) and identify target epitopes in multiple sclerosis (MS). Methods: Peripheral blood mononuclear cells were obtained from 39 MS patients and 19 healthy controls (HCs). TCR repertoires for α/β/δ/γ chains, TCR diversity, and V/J usage were determined by next-generation sequencing. TCR β chain repertoires were compared with affectation status using a novel clustering method, Grouping of Lymphocyte Interactions by Paratope Hotspots (GLIPH). Cytomegalovirus (CMV)-IgG was measured in an additional 113 MS patients and 93 HCs. Regulatory T cells (Tregs) were measured by flow cytometry. Results: TCR diversity for all four chains decreased with age. TCRα and TCRβ diversity was higher in MS patients (P = 0.0015 and 0.024, respectively), even after age correction. TRAJ56 and TRBV4-3 were more prevalent in MS patients than in HCs (pcorr = 0.027 and 0.040, respectively). GLIPH consolidated 208,674 TCR clones from MS patients into 1,294 clusters, among which two candidate clusters were identified. The TRBV4-3 cluster was shared by HLA-DRB1*04:05-positive patients (87.5%) and predicted to recognize CMV peptides (CMV-TCR). MS Severity Score (MSSS) was lower in patients with CMV-TCR than in those without (P = 0.037). CMV-IgG-positivity was associated with lower MSSS in HLA-DRB1*04:05 carriers (P = 0.0053). HLA-DRB1*04:05-positive individuals demonstrated higher CMV-IgG titers than HLA-DRB1*04:05-negative individuals (P = 0.017). CMV-IgG-positive patients had more Tregs than CMV-IgG-negative patients (P = 0.054). Interpretation: High TCRα/TCRβ diversity, regardless of age, is characteristic of MS. Association of a CMV-recognizing TCR with mild disability indicates CMV’s protective role in HLA-DRB1*04:05-positive MS.
UR - http://www.scopus.com/inward/record.url?scp=85099045260&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85099045260&partnerID=8YFLogxK
U2 - 10.1002/acn3.51264
DO - 10.1002/acn3.51264
M3 - Article
C2 - 33400858
AN - SCOPUS:85099045260
SN - 2328-9503
VL - 8
SP - 163
EP - 176
JO - Annals of Clinical and Translational Neurology
JF - Annals of Clinical and Translational Neurology
IS - 1
ER -